androstenedione has been researched along with orphenadrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Murray, M; Reidy, GF | 1 |
| Mehta, I; Murray, M; Reidy, GF | 1 |
3 other study(ies) available for androstenedione and orphenadrine
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Evidence for complexation of P-450 IIC6 by an orphenadrine metabolite.
Topics: Androstenedione; Animals; Cytochrome P-450 CYP2B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ferricyanides; Kinetics; Microsomes, Liver; Orphenadrine; Oxidoreductases; Phenobarbital; Progesterone; Rats; Steroid Hydroxylases | 1990 |
Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
Topics: Androstenedione; Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ferricyanides; In Vitro Techniques; Isoenzymes; Kinetics; Male; Microsomes, Liver; Orphenadrine; Oxidation-Reduction; Rats; Rats, Inbred Strains; Steroid Hydroxylases | 1989 |